Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmocokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis

Autor: Alffenaar, J. W. C., van Altena, R., Bökkerink, H. J., Luijckx, G. J., van Soolingen, D., Aarnoutse, R. E., van der Werf, T. S.

Publikováno v: Clinical Infectious Diseases, 2009 Oct 01. 49(7), 1080-1082.

Externí odkaz: https://www.jstor.org/stable/27799270

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT)

Autor: Van Den Elsen S. H. J., Sturkenboom M. G. G., Akkerman O., Barkane L., Bruchfeld J., Eather G., Heysell S. K., Hurevich H., Kuksa L., Kunst H., Kuhlin J., Manika K., Moschos C., Mpagama S. G., Munoz Torrico M., Skrahina A., Sotgiu G., Tadolini M., Tiberi S., Volpato F., Van Der Werf T. S., Wilson M. R., Zuniga J., Touw D. J., Migliori G. B., Alffenaar J. -W.

Publikováno v: BMJ Open, Vol 10, Iss 6 (2020)
BMJ Open, 10(6):e035350. BMJ PUBLISHING GROUP
BMJ Open

IntroductionGlobal multidrug-resistant tuberculosis (MDR-TB) treatment success rates remain suboptimal. Highly active WHO group A drugs moxifloxacin and levofloxacin show intraindividual and interindividual pharmacokinetic variability which can cause

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8cfada88501c27e9fb6a43fbc9a0dbb
https://research.rug.nl/en/publications/70050145-d4f7-4df7-a7ef-597ab93f20ca

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis : an individual patient data meta-analysis

Autor: Ahmad, N., Ahuja, S. D., Akkerman, O. W., Alffenaar, J. W. C., Anderson, L. F., Baghaei, P., Bang, D., Barry, P. M., Bastos, M. L., Behera, D., Benedetti, A., Bisson, G. P., Boeree, M. J., Bonnet, Maryline, Brode, S. K., Brust, J. C. M., Cai, Y., Caumes, E., Cegielski, J. P., Centis, R., Chan, P. C., Chan, E. D., Chang, K. C., Charles, M., Cirule, A., Dalcolmo, M. P., D'Ambrosio, L., de Vries, G., Dheda, K., Esmail, A., Flood, J., Fox, G. J., Frechet-Jachym, M., Fregona, G., Gayoso, R., Gegia, M., Gler, M. T., Gu, S., Guglielmetti, L., Holtz, T. H., Hughes, J., Isaakidis, P., Jarlsberg, L., Kempker, R. R., Keshavjee, S., Khan, F. A., Kipiani, M., Koenig, S. P., Koh, W. J., Kritski, A., Kuksa, L., Kvasnovsky, C. L., Kwak, N., Lan, Z. Y., Lange, C., Laniado-Laborin, R., Lee, M., Leimane, V., Leung, C. C., Leung, E. C. C., Li, P. Z., Lowenthal, P., Maciel, E. L., Marks, S. M., Mase, S., Mbuagbaw, L., Migliori, G. B., Milanov, V., Miller, A. C., Mitnick, C. D., Modongo, C., Mohr, E., Monedero, I., Nahid, P., Ndjeka, N., O'Donnell, M. R., Padayatchi, N., Palmero, D., Pape, J. W., Podewils, L. J., Reynolds, I., Riekstina, V., Robert, J., Rodriguez, M., Seaworth, B., Seung, K. J., Schnippel, K., Shim, T. S., Singla, R., Smith, S. E., Sotgiu, G., Sukhbaatar, G., Tabarsi, P., Tiberi, S., Trajman, A., Trieu, L., Udwadia, Z. F., van der Werf, T. S., Veziris, N., Viiklepp, P., Vilbrun, S. C., Walsh, K., Westenhouse, J., Yew, W. W., Yim, J. J., Zetola, N. M., Zignol, M., Menzies, D., Collaborative Group Meta-Analysis

Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______932::3ef87a587a5f3deafcd5e782b67f464b
http://www.documentation.ird.fr/hor/fdi:010074011